151. Age-related increase in expression of TGF-beta1 in the rat kidney
- Author
-
Marco Masseroli, Diego Rodríguez-Puyol, Cristina M. Ramírez, C Pérez-Caballero, Manuel Rodríguez-Puyol, María Piedad Ruiz-Torres, R. G. Del Moral, Francisco O'Valle, Ricardo J. Bosch, and M. C. Iglesias
- Subjects
Male ,Aging ,medicine.medical_specialty ,Pathology ,Captopril ,Kidney Cortex ,Transcription, Genetic ,Renal cortex ,Kidney Glomerulus ,Angiotensin-Converting Enzyme Inhibitors ,Kidney ,Polymerase Chain Reaction ,Excretion ,Transforming Growth Factor beta ,Fibrosis ,Internal medicine ,medicine ,Animals ,RNA, Messenger ,Rats, Wistar ,business.industry ,Glomerulosclerosis ,Kidney metabolism ,General Medicine ,medicine.disease ,Immunohistochemistry ,Rats ,Proteinuria ,Endocrinology ,medicine.anatomical_structure ,Nephrology ,business ,medicine.drug ,Kidney disease - Abstract
In the kidney, aging is characterized by the development of structural changes, including glomerulosclerosis and interstitial fibrosis. Transforming growth factor-beta1 (TGF-beta1) is known to play a critical role in the genesis of these alterations in pathologic conditions. The present experiments were designed to test the hypothesis that TGF-beta1 may be involved in the development of age-related histopathologic changes in rat kidney, and that captopril, an angiotensin-converting enzyme inhibitor, may influence the progression of glomerular and interstitial lesions. In this study, 3-, 18-, 24-, and 30-mo-old rats were examined, and an age-related increase in urinary protein excretion was found; plasma creatinine and systolic BP did not change. Significant structural changes, including glomerular sclerosis and interstitial fibrosis, were found in the group of aged rats (24- and 30-mo-old). Immunostaining for TGF-beta in the renal cortex interstitium was increased in the group of 24-mo-old rats, with a parallel increase in TGF-beta1 mRNA expression, measured with reverse-transcription PCR. Captopril-treated animals showed a statistically significant decrease in urinary protein excretion but no significant changes in BP. Moreover, captopril reduced the extent of interstitial fibrosis, but did not affect the degree of glomerulosclerosis. A significant inhibition of TGF-beta1 mRNA expression was observed in the captopril-treated animals. These findings suggest that TGF-beta1 may act as a fibrogenic growth factor that could be responsible, at least partially, for the renal interstitial fibrosis associated with aging. Treatment with captopril might delay the progression of these lesions.
- Published
- 1998
- Full Text
- View/download PDF